Colony-stimulating factor-1 in immunity and inflammation.

Colony-stimulating factor-1 (CSF-1, also known as macrophage-CSF) is the primary regulator of the survival, proliferation, differentiation and function of mononuclear phagocytes. Studies that involve CSF-1-deficient mice demonstrate that there is a variable requirement for CSF-1 in the development of individual mononuclear phagocyte populations. However, these cells uniformly express the CSF-1 receptor, and their morphology, phagocytosis and responsiveness to infectious and non-infectious stimuli is regulated by CSF-1. CSF-1 plays important roles in innate immunity, cancer and inflammatory diseases, including systemic lupus erythematosus, arthritis, atherosclerosis and obesity. In several conditions, activation of macrophages involves a CSF-1 autocrine loop. In addition, secreted and cell-surface isoforms of CSF-1 can have differential effects in inflammation and immunity.

[1]  K. Schäkel,et al.  The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting , 2002, The Journal of experimental medicine.

[2]  H. Hamada,et al.  Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-γ , 2000, Gene Therapy.

[3]  Makoto Naito,et al.  Development, differentiation, and maturation of Kupffer cells , 1998, Microscopy research and technique.

[4]  V. Kelley,et al.  Negative Role of Colony-Stimulating Factor-1 in Macrophage, T Cell, and B Cell Mediated Autoimmune Disease in MRL-Faslpr Mice1 , 2004, The Journal of Immunology.

[5]  N. Athanasou,et al.  Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. , 2002, The Journal of bone and joint surgery. British volume.

[6]  K. Akagawa.  Functional Heterogeneity of Colony-Stimulating Factor-Induced Human Nonocyte-Derived Macrophages , 2002, Respirology.

[7]  W. D. de Villiers,et al.  Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Kohsaka,et al.  Microglia: activation and their significance in the central nervous system. , 2001, Journal of biochemistry.

[9]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[10]  E. Jeffes,et al.  Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  R. Atkins,et al.  Blockade of Macrophage Colony‐Stimulating Factor Reduces Macrophage Proliferation and Accumulation in Renal Allograft Rejection , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  P. Godowski,et al.  Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[13]  E. Jeffes,et al.  Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  B. Kacinski.  CSF‐1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract , 1997, Molecular Reproduction and Development.

[15]  T. Curiel,et al.  Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-121 , 2000, The Journal of Immunology.

[16]  K. Takagi,et al.  Neonatal changes of osteoclasts in osteopetrosis (op/op) mice defective in production of functional macrophage colony-stimulating factor (M-CSF) protein and effects of M-CSF on osteoclast development and differentiation. , 1996, Journal of submicroscopic cytology and pathology.

[17]  A. Tenner,et al.  Macrophage colony stimulatory factor and interferon‐γ trigger distinct mechanisms for augmentation of β‐amyloid‐induced microglia‐mediated neurotoxicity , 2004 .

[18]  D. Hume,et al.  Colony-Stimulating Factor-1 Suppresses Responses to CpG DNA and Expression of Toll-Like Receptor 9 but Enhances Responses to Lipopolysaccharide in Murine Macrophages1 , 2002, The Journal of Immunology.

[19]  J. Salamero,et al.  Modulation of MHC class II transport and lysosome distribution by macrophage-colony stimulating factor in human dendritic cells derived from monocytes. , 2001, Journal of cell science.

[20]  R. Russell,et al.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. , 2002, Blood.

[21]  D. Hume,et al.  The Colony-Stimulating Factor 1 Receptor Is Expressed on Dendritic Cells during Differentiation and Regulates Their Expansion1 , 2005, The Journal of Immunology.

[22]  C. Eaves,et al.  Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages , 1997, Cancer Immunology, Immunotherapy.

[23]  L. Shultz,et al.  Effects of macrophage‐colony‐stimulating factor deficiency on the maturation of microglia and brain macrophages and on their expression of scavenger receptor , 2000, Neuropathology : official journal of the Japanese Society of Neuropathology.

[24]  A. Daugherty,et al.  Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice. , 2006, Atherosclerosis.

[25]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[26]  F. Di Virgilio,et al.  Alerting and tuning the immune response by extracellular nucleotides , 2003, Journal of leukocyte biology.

[27]  J. Pollard,et al.  Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. , 2003, Immunity.

[28]  L. Minasian,et al.  CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. , 1995, Blood.

[29]  J. Tanabe,et al.  Quantitative analysis of apolipoprotein E secretion by human monocyte-derived macrophages in culture. , 2003, The Tohoku journal of experimental medicine.

[30]  K. Motoyoshi,et al.  Biological activities and clinical application of M-CSF. , 1998, International journal of hematology.

[31]  D. Golde,et al.  Colony‐stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells , 1993, British journal of haematology.

[32]  R. Arceci,et al.  The Nikolas Symposia and histiocytosis , 2005, Nature Reviews Cancer.

[33]  Xiao-tong Ma,et al.  Effects of various inducers on the expression of P2X7 receptor in human peripheral blood mononuclear cells. , 2005, Sheng li xue bao : [Acta physiologica Sinica].

[34]  Y. Imai,et al.  Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1 , 2002, Glia.

[35]  A. Langnas,et al.  Xenogeneic skin graft rejection in M‐CSF/macrophage deficient osteopetrotic mice , 2003, Xenotransplantation.

[36]  J. Hamilton,et al.  Exacerbation of acute inflammatory arthritis by the colony‐stimulating factors CSF‐1 and granulocyte macrophage (GM)‐CSF: evidence of macrophage infiltration and local proliferation , 2000, Clinical and experimental immunology.

[37]  T. Davis,et al.  Mice with a regenerative wound healing capacity and an SLE autoimmune phenotype contain elevated numbers of circulating and marrow-derived macrophage progenitor cells. , 2005, Blood cells, molecules & diseases.

[38]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[39]  J. Pollard,et al.  Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. , 2001, Blood.

[40]  K. Tanne,et al.  Amyloid β protein deposition and neuron loss in osteopetrotic (op/op) mice , 2003 .

[41]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[42]  Y. Matsuzawa,et al.  Induction of Macrophage Colony-stimulating Factor Receptor (c-fms) Expression in Vascular Medial Smooth Muscle Cells Treated with Heparin Binding Epidermal Growth Factor-like Growth Factor* , 1996, The Journal of Biological Chemistry.

[43]  E. Stanley,et al.  Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. , 2004, Blood.

[44]  M. Jadus,et al.  Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins , 2003, Cancer Gene Therapy.

[45]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[46]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[47]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[48]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[49]  D. Davies,et al.  Human peripheral blood contains two distinct lineages of dendritic cells , 1999, European journal of immunology.

[50]  E. Stanley,et al.  Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice , 2004, Cancer Research.

[51]  J. Hamilton,et al.  The colony‐stimulating factors and collagen‐induced arthritis: exacerbation of disease by M‐CSF and G‐CSF and requirement for endogenous M‐CSF , 2000, Journal of leukocyte biology.

[52]  R. Atkins,et al.  Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. , 2002, Transplantation.

[53]  J. Pollard,et al.  Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. , 1994, Development.

[54]  J. Pollard,et al.  Pleiotropic Roles for CSF-1 in Development Defined by the Mouse Mutation Osteopetrotic , 1996 .

[55]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[56]  G. Granger,et al.  Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor. , 1997, Journal of immunology.

[57]  S. Nishikawa,et al.  Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice. , 1999, Circulation.

[58]  F. Luscinskas,et al.  Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.

[59]  Connie Phong,et al.  Microglia Overexpressing the Macrophage Colony-Stimulating Factor Receptor Are Neuroprotective in a Microglial-Hippocampal Organotypic Coculture System , 2005, The Journal of Neuroscience.

[60]  S. Gordon,et al.  Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function , 1994, The Journal of experimental medicine.

[61]  H. Makino,et al.  CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[62]  Helen Neale,et al.  Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. , 2005, Immunobiology.

[63]  H. Makino,et al.  Expression of Fc Gamma Receptor III (CD16) on Monocytes during Hemodialysis in Patients with Chronic Renal Failure , 2001, Nephron.

[64]  H. Broxmeyer,et al.  Macrophage Colony-Stimulating Factor Drives Cord Blood Monocyte Differentiation into IL-10highIL-12absent Dendritic Cells with Tolerogenic Potential1 , 2005, The Journal of Immunology.

[65]  W. Liles,et al.  Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. , 2002, The Journal of infectious diseases.

[66]  O. Mitrasinovic,et al.  Macrophage colony stimulating factor promotes phagocytosis by murine microglia , 2003, Neuroscience Letters.

[67]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[68]  X. Ji,et al.  Interaction between M-CSF and IL-10 on productions of IL-12 and IL-18 and expressions of CD14, CD23, and CD64 by human monocytes. , 2004, Acta pharmacologica Sinica.

[69]  J. Nemunaitis,et al.  Use of macrophage colony-stimulating factor in the treatment of fungal infections. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  M. Ernst,et al.  Heterogeneity of human peripheral blood monocyte subsets , 2001, Journal of leukocyte biology.

[71]  G. Murphy,et al.  Proinflammatory effects of M-CSF and Aβ in hippocampal organotypic cultures , 2002, Neurobiology of Aging.

[72]  M. Akhter,et al.  Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain. , 2006, Blood.

[73]  G. Murphy,et al.  Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease. , 2000, The American journal of pathology.

[74]  P. Libby,et al.  Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. , 1998, The Journal of clinical investigation.

[75]  S. Nakagawa,et al.  Macrophage colony-stimulating factor in cooperation with transforming growth factor-beta1 induces the differentiation of CD34+ hematopoietic progenitor cells into Langerhans cells under serum-free conditions without granulocyte-macrophage colony-stimulating factor. , 2003, The Journal of investigative dermatology.

[76]  A. Hao,et al.  Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage , 2002, Neuroscience.

[77]  Michael C. Ostrowski,et al.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. , 2003, Blood.

[78]  T. Tsuruo,et al.  Combined therapy with anti‐p‐glycoprotein antibody and macrophage colony‐stimulating factor gene transduction for multiorgan metastases of multidrug‐resistant human small cell lung cancer in nk cell‐depleted scid mice , 1999, International journal of cancer.

[79]  G. Vanham,et al.  Generalized immune activation in pulmonary tuberculosis: co‐activation with HIV infection , 1996, Clinical and experimental immunology.

[80]  B. Blazar,et al.  Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non- depleted syngeneic bone marrow transplants , 1992 .

[81]  A. Sabokbar,et al.  Synovial macrophage-osteoclast differentiation in inflammatory arthritis , 2002, Annals of the rheumatic diseases.

[82]  L. Shultz,et al.  Ultrastructure of macrophages and dendritic cells in osteopetrosis (op) mutant mice lacking macrophage colony-stimulating factor (M-CSF/CSF-1) activity. , 1994, Journal of submicroscopic cytology and pathology.

[83]  E. Stanley,et al.  Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. , 2002, Cancer research.

[84]  J. Levine,et al.  Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. , 1998, The Journal of clinical investigation.

[85]  V. Kelley,et al.  Reduced Macrophage Recruitment, Proliferation, and Activation in Colony-Stimulating Factor-1-Deficient Mice Results in Decreased Tubular Apoptosis During Renal Inflammation 1 , 2003, The Journal of Immunology.

[86]  K. Takagi,et al.  Effects of macrophage colony-stimulating factor on macrophages and their related cell populations in the osteopetrosis mouse defective in production of functional macrophage colony-stimulating factor protein. , 1996, The American journal of pathology.